All CIPLA news

2 days ago Cipla’s inhalable insulin fails to get approval for trials on Indian patients - The Economic Times
2 days ago Kloseby, ShopsUp, Affordplan and more: Check out the rising startups in India - Business Standard India
5 days ago Negative global cues suppress Indian equities ( - newkerala.com #150069 - New Kerala
5 days ago Sensex slumps 329 points, Nifty finishes below 8,100 - The Hindu
5 days ago Sensex drops 329 points,ends at 26,231 over global concerns - dna
5 days ago Sensex, Nifty Bank plunge over 200 points; Tata Motors down 3% - Business Standard India
6 days ago Delhi High Court sets aside ban on 344 fixed dose combination drugs - asianage
6 days ago Delhi HC sets aside ban on 344 combination drugs - The Hindu
6 days ago HC quashes government notification banning FDC drugs - newkerala.com #149653 - New Kerala
6 days ago Blow to Centre as Delhi HC quashes ban on 344 fixed dose medicines - Decclan Chronicle
6 days ago Delhi HC sets aside Centre's decision to ban 344 fixed dose combination drugs - The Hindu
6 days ago Sensex, Nifty turn range-bound; GAIL gains over 2.5% - Business Standard India
6 days ago Delhi HC sets aside Centre's ban on 344 drugs - newkerala.com #149371 - New Kerala
6 days ago Delhi HC quashes ban on 344 FDC medicines - asianage
6 days ago Sensex cuts initial gains, Nifty holds 8,200-mark - asianage
6 days ago Delhi High Court quashes ban on 344 fixed-dose combination drugs - The Telegraph
6 days ago Delhi High Court quashes government ban on over 300 medicines like Corex, Saridon - The Economic Times
6 days ago Delhi HC sets aside Centre's decision to ban 344 fixed dose combination medicines - The Hindu
6 days ago Pharma stocks rise after Delhi HC sets aside govt ban on fixed dose combination drugs - Business Standard India
6 days ago Delhi High court quashes centre's ban on 344 combination drugs - Business Standard India
6 days ago HC quashes Centre's notification to ban FDC drugs - newkerala.com #149357 - New Kerala
6 days ago Delhi HC quashes centre's ban on 344 fixed dose drugs - dna
7 days ago Sensex ends at two-weeks high, Nifty reclaims 8,200 on oil spike - dna
7 days ago Global cues, rupee appreciation lift equity markets ( - newkerala.com #149166 - New Kerala
8 days ago 200 'high-risk' drug firms come under Indian regulator lens - Business Standard India
8 days ago Cipla appoints Ireena Vittal as independent director - The Economic Times
8 days ago Sensex up over 150 points, Smallcap outperforms; auto shares gain - Business Standard India
9 days ago Sensex moves up 34 points over sustained buying in telecom, power - dna
9 days ago Late recovery helps Sensex close in green; realty, power up - The Hindu
9 days ago Sensex up 34 points to end at 26,350 - asianage
9 days ago Sensex turns flat as banking stocks recover; Airtel top gainer - Business Standard India
9 days ago Cipla Shares: Cipla jumps 2% after UK arm sells stake in Chase Pharma - The Economic Times
9 days ago Sensex rebounds as banking stocks recover; PowerGrid top gainer - Business Standard India
9 days ago Sensex trades at day's high as banking stocks recover - Business Standard India
9 days ago Sensex up by 32 points in late morning trade - asianage
10 days ago 27 medicines sold by top firms ‘fail’ quality tests in seven states - The Indian Express
12 days ago Sensex rallies 456 points as rupee racks up big gains - The Hindu
12 days ago Pharma shares in focus; Lupin, Sun Pharma, Aurobindo up over 3% - Business Standard India
14 days ago Cipla divests 16.7% stake in Chase Pharma to Allergan - Business Standard India
14 days ago Cipla divests 16.7% stake in Chase Pharma to Allergan - dna
15 days ago Quality Chemicals Plans IPO? - AllAfrica.com
15 days ago Nifty holds 7,950 amid choppy trades; metal & oil shares gain - Business Standard India
16 days ago New HIV infections fall in India, but stigma remains: UNAIDS - Hindustantimes.com
18 days ago Owning up to the onus - The Hindu
19 days ago Nifty nears 6-month low, Sensex ends 77 points lower - Business Standard India
19 days ago Sensex trades flat, Nifty below 8,100; Rupee hits 68 mark - Business Standard India
20 days ago Stocks end at six-month low - Business Standard India
20 days ago Possible US rate hike, political bickering subdue equities ( - New Kerala
20 days ago CEOs of pharma companies to discuss key challenges within industry - The Economic Times
21 days ago Cipla plans to get more aggressive in US, UK - Business Standard India

Create a custom search

News search supports Google type search formatting and the use of complex boolean. Wrap terms in double quotes for exact phrase matching. Click + to add multiple news search terms to this topic.